Synergistic Anticancer Effects of Vorinostat and Epigallocatechin-3-Gallate against HuCC-T1 Human Cholangiocarcinoma Cells

The aim of this study was to investigate the effect of the combination of vorinostat and epigallocatechin-3-gallate against HuCC-T1 human cholangiocarcinoma cells. A novel chemotherapy strategy is required as cholangiocarcinomas rarely respond to conventional chemotherapeutic agents. Both vorinostat...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Kwak, Tae Won, Kim, Do Hyung, Chung, Chung-Wook, Lee, Hye Myeong, Kim, Cy Hyun, Jeong, Young-IL, Kang, Dae Hwan
Format: Artigo
Jezik:Inglês
Izdano: Hindawi Publishing Corporation 2013
Teme:
Research Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3706064/
https://ncbi.nlm.nih.gov/pubmed/23864881
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2013/185158
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items